individualizing the selection of first-line therapy for patients with hr-positive metastatic bc
Published 1 month ago • 135 plays • Length 1:14:37Download video MP4
Download video MP3
Similar videos
-
1:15:00
individualizing the selection of first-line therapy for patients with hormone receptor-positive m...
-
5:32
first-line er-positive metastatic breast cancer treatments
-
7:34
first-line therapy for hr-positive, her2-negative, mbc
-
2:24
identifying drivers of first-line hr /her2- metastatic breast cancer treatment choices
-
9:57
how to select 1st line therapy for metastatic renal cell cancer?
-
8:40
first-line treatment of her2-positive metastatic breast cancer
-
6:08
first-line treatment of her2-positive metastatic breast cancer
-
10:19
quality of life for women with hr-positive breast cancer
-
5:01
cdk4/6 inhibitors: sequencing endocrine therapy for metastatic breast cancer
-
5:07
tropics-02: sacituzumab govetican improves pfs versus physicians choice for hr /her2- mbc
-
7:36
asco 2022: metastatic breast cancer drug therapy recap
-
2:09
the evolution of her2 targeting in metastatic breast breast cancer
-
5:37
therapeutic landscape for patients with her2-positive breast cancer with active brain metastases
-
29:09
interactive case: choosing and using cdk4/6 inhibitors in breast cancer - first-line therapy
-
59:56
research update on metastatic breast cancer
-
7:00
upfront treatment of hr-positive metastatic breast cancer
-
4:22
how to use endocrine therapy in premenopausal women with er metastatic breast cancer
-
51:56
new & supporting data for optimizing therapy in her2 breast cancer | dr. kaklamani and dr. o’regan
-
2:53
early lines of therapy for her2 de novo metastatic breast cancer